相关实验视频

Updated: Jul 10, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

细胞癌中的循环RNA:从机械学到临床的视角

Chunjie Huang¹, Pooya Esfani Sarafraz², Parisa Enayati³

¹School of Medicine, Nantong University, Nantong, China.

Cancer cell international

|November 23, 2023

概括

循环RNAs (circRNAs) 是癌的关键调节者,影响药物耐药性,转移和细胞死亡. 它们的异常表达突出了它们作为癌诊断和治疗标的潜力.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
生物化学生化学

背景情况:

循环RNA (circRNAs) 是一种具有稳定结构的非编码RNA的独特类别.
它们参与关键的细胞功能,包括microRNA海绵和基因表达调节.
异常的circRNA表达与癌的发展有关.

研究的目的:

阐明癌中circRNAs的特征和功能.
为了研究circRNAs在药物耐药性,新陈代谢,转移,细胞生长和亡中的作用.
讨论circRNAs作为脏恶性瘤的预后和诊断生物标志物的潜力.

主要方法:

文献综述和关于癌中circRNAs的当前研究的综合.
对circRNA参与关键癌症特征的分析.
在临床诊断和治疗中探索circRNA应用.

主要成果:

循环RNA在癌进展中表现出多种作用,影响关键细胞过程.
异常的circRNA表达模式与癌的各个方面有关.
循环RNA显示出作为诊断和预后的生物标志物以及治疗点的前景.

结论:

循环RNAs是癌病原和进展的组成部分.
了解circRNA功能为癌治疗和早期检测提供了新的途径.
对circRNAs的进一步研究对于推进癌管理至关重要.

关键词:

生物标志物生物标志物循环RNA 是一个循环RNA.细胞癌是细胞癌.有针对性的治疗.

更多相关视频

Identification of Circular RNAs using RNA Sequencing

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...